jrnl2582

Publication Venue For

  • Cumulative average dietary pattern scores in young adulthood and risk of incident type 2 diabetes: the CARDIA study.  62:2233-2244. 2019
  • Fasting glucose variability in young adulthood and incident diabetes, cardiovascular disease and all-cause mortality.  62:1366-1374. 2019
  • Ideal cardiovascular health, glycaemic status and incident type 2 diabetes mellitus: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study.  62:426-437. 2019
  • Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population.  62:269-280. 2019
  • Identification of novel high-impact recessively inherited type 2 diabetes risk variants in the Greenlandic population.  61:2005-2015. 2018
  • Associations between SLC16A11 Variants and Type 2 Diabetes in the Hispanic Community Health Study/Study of Latinos 2017
  • Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study.  60:980-988. 2017
  • Twenty year fitness trends in young adults and incidence of prediabetes and diabetes: the CARDIA study.  59:1659-1665. 2016
  • Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study.  58:2736-2744. 2015
  • FGF21 is not required for glucose homeostasis, ketosis or tumour suppression associated with ketogenic diets in mice.  58:2414-2423. 2015
  • Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial.  58:1803-1813. 2015
  • The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice.  58:1836-1844. 2015
  • A genotype risk score predicts type 2 diabetes from young adulthood: The CARDIA study.  55:2604-2612. 2012
  • Common genetic variants differentially influence the transition from clinically defined states of fasting glucose metabolism.  55:331-339. 2012
  • Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle.  55:457-467. 2012
  • C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes.  54:2713-2723. 2011
  • Decreased progression to diabetes in subjects with prediabetes after 2 years of treatment with controlled-release phentermine/topiramate.  54:S371-S371. 2011
  • Long-term weight loss with controlled-release phentermine/topiramate reverses metabolic syndrome and improves associated traits.  54:S370-S370. 2011
  • Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes.  54:979-988. 2011
  • Colesevelam for Hispanic patients with hypercholesterolaemia and prediabetes.  53. 2010
  • Initial treatment with metformin plus colesevelam provides greater glycaemic control than metformin alone in Hispanic patients with type 2 diabetes mellitus.  53. 2010
  • Once-daily, low-dose, controlled-release phentermine/topiramate results in significant clinical improvements in overweight/obese patients with type 2 diabetes.  53. 2010
  • Phentermine/topiramate combination therapy significantly improves glucose impairment in overweight/obese patients.  53. 2010
  • Glucosamine increases hexosamine biosynthesis and O-linked N-acetylglucosamine in the heart, and leads to metabolic alterations similar to those seen in diabetic cardiomyopathy.  52:S15-S15. 2009
  • Treatment with VI-0521 (phentermine and topiramate) leads to one year durable glycaemic benefit and weight loss in subjects with type 2 diabetes.  52:S77-S77. 2009
  • Changes in O-linked N-acetylglucosamine is associated with diabetic nephropathy in the human kidney.  51:S488-S488. 2008
  • HbA1c measured in stored erythrocytes and mortality rate among middle-aged and older women.  51:267-275. 2008
  • Metabolic aspects of pig-to-monkey (Macaca fascicularis) islet transplantation: Implications for translation into clinical practice.  51:120-129. 2008
  • Genotype-by-sex interaction in the aetiology of type 2 diabetes mellitus: Support for sex-specific quantitative trait loci in Hypertension Genetic Epidemiology Network participants.  49:2329-2336. 2006
  • Erratum: Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families (Diabetologia (2005) 48 (661-668) DOI: http://dx.doi.org/10.1007/s00125-005-1679-5).  48:1678. 2005
  • Genome-wide scans for heritability of fasting serum insulin and glucose concentrations in hypertensive families.  48:661-668. 2005
  • A genome scan for loci linked to quantitative insulin traits in persons without diabetes: The Framingham Offspring Study.  46:579-587. 2003
  • Oxidant regulation of gene expression and neural tube development: Insights gained from diabetic pregnancy on molecular causes of neural tube defects.  46:538-545. 2003
  • Inflammation and the insulin healthy subjects. The atherosclerosis study (IRAS)..  42:A60-A60. 1999
  • Genome scan for linkage to pre-diabetic traits in Pima Indians.  40:615-615. 1997
  • Short-term regulation of insulin-mediated glucose utilization in four-day fasted human volunteers: role of amino acid availability.  35:357-366. 1992
  • Effect of haemolysis on radioimmunoassay for insulin.  31:403-404. 1988
  • Induction of class II MHC antigens on human and rodent islet parenchymal cells in vitro..  30:441. 1987
  • Class I, II and III major histocompatibility complex gene polymorphisms in BB rats.  27:77-79. 1984
  • The complement component C4 in black Americans with Type 1 (insulin-dependent) diabetes mellitus.  26:166-168. 1984
  • Properdin factor B in black Type 1 (insulin-dependent) diabetic patients.  22:483-485. 1982
  • Binding and degradation of 125I-insulin by renal glomeruli and tubules isolated from rats.  22:276-284. 1982